Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use PIMECROLIMUS CREAM safely and effectively. See full prescribing information for PIMECROLIMUS CREAM . PIMECROLIMUS c ream, 1% for topical use Initial U.S. Approval: 2001
Medication labelWhy this: Advisory · dailymed-prescription
Pimecrolimus cream, 1% is indicated as second-line therapy for the short-term and non-continuous chronic treatment of mild to moderate atopic dermatitis in non-immunocompromised adults and children 2 years of age and older, who have failed to respond adequately to other topical prescription treatments, or when those treatments are not advisable. Pimecrolimus c ream, 1% is not indicated for use in children less than 2 years of age [see Warnings and Precautions (5.1) , Use in Specific Populations (8.4) ].
- generic_name
- pimecrolimus
- product_names
- pimecrolimus
- ndc
- 0591-2944, 0591-2944-30, 0591-2944-60, 0591-2944-87
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en